Cutaneous Manifestations of COVID-19: Insights from Recent Research

The COVID-19 pandemic has transformed our understanding of various health conditions, including its cutaneous manifestations. Dermatologists have observed a range of skin symptoms linked to the SARS-CoV-2 virus, prompting a need for greater awareness and understanding in clinical practice. Understanding Cutaneous Symptoms Initially, dermatological signs were not widely recognized as part of the COVID-19 symptomatology. However, recent research has illuminated several key cutaneous manifestations, including: Rash: Various types of rashes have been reported, including maculopapular rashes and urticarial lesions. Pseudo-chilblains: Often referred to as “COVID toes,” these lesions resemble chilblains and appear as painful, erythematous nodules on the toes and fingers. Vesicular lesions: Some patients have experienced vesicular eruptions, resembling those seen in herpes simplex infections. Exanthem: Generalized exanthematous eruptions have also been documented, which may present as widespread rashes. Prevalence and Timing Studies have shown that cutaneous manifestations of COVID-19 may occur in approximately 20% of patients, often appearing during the acute phase or shortly after the onset of other systemic symptoms. Understanding the timing can aid in differential diagnosis, especially in cases where skin symptoms may mimic other dermatologic conditions. Pathophysiology Behind Skin Manifestations The exact mechanisms driving these cutaneous signs remain under investigation, but several hypotheses have been proposed: Viral invasion: The presence of ACE2 receptors in keratinocytes may allow the virus to infect skin cells directly. Immune response: An exaggerated immune response may lead to inflammatory skin reactions, contributing to the diverse dermatological symptoms observed. Vascular phenomena: COVID-19 is associated with thrombotic events, which could explain some of the vascular cutaneous manifestations. Clinical Implications As dermatologists encounter patients wit